Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis

Gastroenterology

Volumn 145, Issue 1, 2013, Pages

  Maruoka, Ryutaro ^a   Aoki, Nobuhiro ^a   Kido, Masahiro ^a   Iwamoto, Satoru ^a   Nishiura, Hisayo ^a   Ikeda, Aki ^a   Chiba, Tsutomu ^a   Watanabe, Norihiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

ANA; Autoimmunity; Necrosis; T Cell Response

Indexed keywords

ANTINUCLEAR ANTIBODY; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; HELPER CELL; HYPERGAMMAGLOBULINEMIA; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; SPLENECTOMY;

EID: 84879491654     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.03.011     Document Type: Article

References (41)

1. E.L. Krawitt Autoimmune hepatitis N Engl J Med 354 2006 54 66
2. M.P. Manns, A.J. Czaja, and J.D. Gorham Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
3. A.J. Czaja, and M.P. Manns Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis Gastroenterology 139 2010 58 72
4. M.P. Manns Autoimmune hepatitis: the dilemma of rare diseases Gastroenterology 140 2011 1874 1876
5. A.J. Czaja, G.L. Davis, and J. Ludwig Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis Hepatology 4 1984 622 627
6. A.J. Czaja Safety issues in the management of autoimmune hepatitis Expert Opin Drug Saf 7 2008 319 333
7. A.J. Czaja, H.V. Ammon, and W.H. Summerskill Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission Gastroenterology 78 1980 518 523
8. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Consequences of treatment withdrawal in type 1 autoimmune hepatitis Liver Int 27 2007 507 515
9. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse Am J Gastroenterol 102 2007 1005 1012
10. B. Hoeroldt, E. McFarlane, and A. Dube Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center Gastroenterology 140 2011 1980 1989
11. M. Kido, N. Watanabe, and T. Okazaki Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling Gastroenterology 135 2008 1333 1343
12. N. Aoki, M. Kido, and S. Iwamoto Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice Gastroenterology 140 2011 1322 1333
13. C. King New insights into the differentiation and function of T follicular helper cells Nat Rev Immunol 9 2009 757 766
14. R.G. Knodell, K.G. Ishak, and W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
15. A.H. Wyllie Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 284 1980 555 556
16. M.M. Compton, and J.A. Cidlowski Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid Endocrinology 118 1986 38 45
17. X. Chen, T. Murakami, and J.J. Oppenheim Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death Eur J Immunol 34 2004 859 869
18. A.J. Czaja, H.A. Carpenter, and P.J. Santrach Significance of HLA DR4 in type 1 autoimmune hepatitis Gastroenterology 105 1993 1502 1507
19. A.J. Czaja, M.D. Strettell, and L.J. Thomson Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis Hepatology 25 1997 317 323
20. H. Nishimura, N. Minato, and T. Nakano Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses Int Immunol 10 1998 1563 1572
21. R.F. Schwabe, and D.A. Brenner Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways Am J Physiol Gastrointest Liver Physiol 290 2006 G583 G589
22. J.R. Oksenberg, S. Stuart, and A.B. Begovich Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients Nature 345 1990 344 346
23. G. Kim, N. Tanuma, and T. Kojima CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis J Immunol 160 1998 509 513
24. C.C. Striebich, M.T. Falta, and Y. Wang Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis J Immunol 161 1998 4428 4436
25. T. Kato, M. Kurokawa, and K. Masuko-Hongo T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions J Immunol 159 1997 5143 5149
26. T. Sekine, T. Kato, and K. Masuko-Hongo Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis Ann Rheum Dis 58 1999 446 450
27. A. Tanaka, S. Iwabuchi, and M. Takatori Clonotypic analysis of T cells in patients with autoimmune and viral hepatitis Hepatology 25 1997 1070 1076
28. H.F. Löhr, S. Pingel, and S. Weyer Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis Scand J Immunol 57 2003 384 390
29. M. Arenz, S. Pingel, and P. Schirmacher T cell receptor Vβ chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients Liver 21 2001 18 25
30. D. Dieckmann, H. Plottner, and S. Berchtold Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood J Exp Med 193 2001 1303 1310
31. C. Baecher-Allan, J.A. Brown, and G.J. Freeman CD4+CD25 high regulatory cells in human peripheral blood J Immunol 167 2001 1245 1253
32. W. Liu, A.L. Putnam, and Z. Xu-Yu CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 2006 1701 1711
33. H. Nishimura, N. Minato, and T. Nakano Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses Int Immunol 10 1998 1563 1572
34. H. Nishimura, T. Okazaki, and Y. Tanaka Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 2001 319 322
35. Y. Shinkai, G. Rathbun, and K.P. Lam RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement Cell 68 1992 855 867
36. M. Kido, N. Watanabe, and T. Okazaki Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling Gastroenterology 135 2008 1333 1343
37. N. Aoki, M. Kido, and S. Iwamoto Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice Gastroenterology 140 2011 1322 1333
38. K.D. Klonowski, A.L. Marzo, and K.J. Williams CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen J Immunol 177 2006 6738 6746
39. M. Muramatsu, K. Kinoshita, and S. Fagarasan Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 2000 553 563
40. G. Blobel, and V.R. Potter Nuclei from rat liver: isolation method that combines purity with high yield Science 154 1966 1662 1665
41. R.G. Knodell, K.G. Ishak, and W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435